JP2012518007A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012518007A5 JP2012518007A5 JP2011550276A JP2011550276A JP2012518007A5 JP 2012518007 A5 JP2012518007 A5 JP 2012518007A5 JP 2011550276 A JP2011550276 A JP 2011550276A JP 2011550276 A JP2011550276 A JP 2011550276A JP 2012518007 A5 JP2012518007 A5 JP 2012518007A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- use according
- compound
- pharmaceutical composition
- composition comprises
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15249409P | 2009-02-13 | 2009-02-13 | |
| US61/152,494 | 2009-02-13 | ||
| PCT/US2010/024111 WO2010093930A1 (en) | 2009-02-13 | 2010-02-12 | Pharmaceutical compositions comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012518007A JP2012518007A (ja) | 2012-08-09 |
| JP2012518007A5 true JP2012518007A5 (https=) | 2013-03-28 |
Family
ID=42083967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011550276A Pending JP2012518007A (ja) | 2009-02-13 | 2010-02-12 | （３‐（１‐（１ｈ‐イミダゾール‐４‐イル）エチル）‐２‐メチルフェニル）メタノールを含む医薬組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US20110301214A1 (https=) |
| EP (3) | EP3241553B1 (https=) |
| JP (1) | JP2012518007A (https=) |
| AU (1) | AU2010213580A1 (https=) |
| CA (1) | CA2752148A1 (https=) |
| DK (1) | DK3566703T3 (https=) |
| ES (3) | ES2649018T3 (https=) |
| HK (1) | HK1246204B (https=) |
| WO (1) | WO2010093930A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8492557B2 (en) * | 2010-09-16 | 2013-07-23 | Allergan, Inc. | Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol |
| KR102050187B1 (ko) | 2010-11-16 | 2019-11-28 | 알러간, 인코포레이티드 | (3-(1-(1h-이미다졸-4-일)에틸)-2-메틸페닐)메탄올을 포함하는 약제학적 조성물 |
| CA2842866A1 (en) | 2011-07-22 | 2013-01-31 | Allergan, Inc. | Alpha-2 adrenergic modulators for treating visual disorders mediated by central visual projections from the eye |
| EP2782569A1 (en) * | 2011-11-21 | 2014-10-01 | Allergan, Inc. | Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole derivatives for treating retinal diseases |
| JP2025542586A (ja) * | 2022-12-27 | 2025-12-26 | アルセプター セラピューティクス， インコーポレイテッド | 興奮治療のための（ｓ）－（３－（１－（１ｈ－イミダゾール－４－イル）エチル）－２－メチルフェニル）メタノール |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| US5344840A (en) | 1988-02-29 | 1994-09-06 | Orion-Yhtyma Oy | 4-substituted imidazole derivatives useful in perioperative care |
| GB2215206B (en) * | 1988-02-29 | 1991-07-03 | Farmos Oy | 4-substituted imidazole derivatives useful in perioperative care |
| FI894911A0 (fi) | 1989-10-17 | 1989-10-17 | Farmos Oy | En terapeutiskt vaerdefull foerening. |
| UA78529C2 (en) * | 2001-10-10 | 2007-04-10 | Wyeth Corp | Derivatives of [[2-(amino-3,4-dioxo-1-cyclobutene-1-yl)amino]alkyl] acid for treating pain |
| US8492557B2 (en) * | 2010-09-16 | 2013-07-23 | Allergan, Inc. | Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol |
| KR102050187B1 (ko) | 2010-11-16 | 2019-11-28 | 알러간, 인코포레이티드 | (3-(1-(1h-이미다졸-4-일)에틸)-2-메틸페닐)메탄올을 포함하는 약제학적 조성물 |
| EP2782569A1 (en) | 2011-11-21 | 2014-10-01 | Allergan, Inc. | Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole derivatives for treating retinal diseases |
-
2010
- 2010-02-12 EP EP17174959.1A patent/EP3241553B1/en active Active
- 2010-02-12 JP JP2011550276A patent/JP2012518007A/ja active Pending
- 2010-02-12 US US13/147,760 patent/US20110301214A1/en not_active Abandoned
- 2010-02-12 ES ES10706824.9T patent/ES2649018T3/es active Active
- 2010-02-12 AU AU2010213580A patent/AU2010213580A1/en not_active Abandoned
- 2010-02-12 EP EP10706824.9A patent/EP2395999B1/en active Active
- 2010-02-12 CA CA2752148A patent/CA2752148A1/en not_active Abandoned
- 2010-02-12 EP EP19168102.2A patent/EP3566703B1/en active Active
- 2010-02-12 ES ES19168102T patent/ES2880578T3/es active Active
- 2010-02-12 DK DK19168102.2T patent/DK3566703T3/da active
- 2010-02-12 ES ES17174959T patent/ES2733905T3/es active Active
- 2010-02-12 WO PCT/US2010/024111 patent/WO2010093930A1/en not_active Ceased
-
2014
- 2014-11-21 US US14/550,647 patent/US9193690B2/en active Active
-
2015
- 2015-10-19 US US14/886,457 patent/US9555021B2/en active Active
-
2018
- 2018-05-08 HK HK18105920.4A patent/HK1246204B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013525444A5 (https=) | ||
| JP2013032389A5 (https=) | ||
| JP2013532687A5 (https=) | ||
| JP2014507446A5 (https=) | ||
| JP2011518833A5 (https=) | ||
| JP2015501783A5 (https=) | ||
| JP2011105738A5 (https=) | ||
| JP2015513557A5 (https=) | ||
| JP2017537066A5 (https=) | ||
| JP2012107057A5 (https=) | ||
| JP2013523733A5 (https=) | ||
| JP2014515013A5 (https=) | ||
| JP2009149903A5 (https=) | ||
| JP2013508347A5 (https=) | ||
| JP2013014622A5 (https=) | ||
| MX2012006233A (es) | Nuevos compuestos de espiropiperidina. | |
| JP2012518007A5 (https=) | ||
| EP3404029A3 (en) | Pyrimido-pyridazinone compounds and methods and use thereof | |
| PH12013500301A1 (en) | Oxadiazole inhibitors of leukotriene production | |
| JP2011510079A5 (https=) | ||
| JP2011037885A5 (https=) | ||
| EP2496251A4 (en) | METHOD, COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY DISEASES | |
| JP2011519871A5 (https=) | ||
| IL232384A (en) | Use of lupanate compounds or lupanic acid for the preparation of anti-gout drugs | |
| EP3133073A3 (en) | Inhibitors of iap |